Skip to main content
. 2019 Mar 6;11(3):108. doi: 10.3390/pharmaceutics11030108

Table 2.

Input parameters for PBPK modeling of PA and NAPA.

Parameter Value (CV%) Comments
PA NAPA
Physchem and Blood Binding
Molecular weight 235.33 277.36 -
Compound type Monoprotic base -
pKa 9.04 9.04 Predicted a
log P 0.83 0.93 Predicted a
fup 0.870 0.688 Measured (PA), estimated (NAPA)
B/P ratio (R) 1 1 Assumed (see text) [28]
Distribution (Kp)
Kidney 8.31 31.2 Corrected with ER b
Liver 11.7 19.6 Corrected with ER b,c
Brain, heart, lung, and spleen - - Determined (Same with Kp,ss) c
Other tissues - - Predicted—Rodgers and Rowland method [49]
Semi-Mechanistic Kidney
CLu,int,r (mL/min) 4.67 (16.0) 9.16 (22.5) Retrograde calculation b
PSin (mL/min) 16.2 20.3 Retrograde calculation b
PSout (mL/min) 7.61 7.61 d Scaled from PAMPA permeability [44,54] e
CLrabs (mL/min) 0.415 0.415 d Retrograde calculation b
ER f 0.316 0.327 Determined (see text)
fu,kidney 0.223 0.0588 Predicted—Rodgers and Rowland method [49]
Non-Renal Elimination
CLu,int (mL/min) 69.0 2.88 Retrograde calculation b
ER f 0.756 0.0918 Determined (see text)
FNAPA 0.534 Retrograde calculation b

a ChemAxon MarvinSketch 15.5.11.0 (http://www.chemaxon.com/products/marvin); b See text for detailed calculations; c For the co-treatment condition, Kp values for brain, heart, lung, and spleen tissues were adopted from the Kp,ss values experimentally determined in this study. For the liver compartment, extraction ratio estimated from calculated CLNR of PA and NAPA was used for the correction of Kp,ss; d In this study, parallel artificial membrane permeability assay (PAMPA) permeability and reabsorption clearance of NAPA was assumed to be the same with PA; e Seff normalized by g kidney was multiplied by the volume of proximal tubule cells, assuming the tissue density is unity; f Extraction ratio determined for the control group.